?> Contact us Follow Us
Biosimilars Forum
  • About Us
    • Members
    • Executive Director
  • Why Biosimilars
  • Biosimilars 101
  • Policies
    • Biosimilars are a Free-Market Solution
    • The Biosimilar Access and Affordability Act
  • News
  • Resources

Archives: Resources

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
July 3, 2019 Biosimilars Forum
Five Things to Know About Biosimilars
July 3, 2019 Biosimilars Forum
Awareness, Knowledge & Perceptions of Biosimilars among Specialty Physicians
July 3, 2019 Biosimilars Forum
States Continue to Pass Biosimilar Substitution Laws in 2018
July 3, 2019 Biosimilars Forum
FDA Guidance: Additional Q&A Regarding Implementation of the BPCIA (2021)
July 3, 2019 Biosimilars Forum
FDA Guidance: Q&A Regarding Implementation of the BPCIA (2021)
July 3, 2019 Biosimilars Forum
FDA Draft Guidance: Reference Product Exclusivity
July 3, 2019 Biosimilars Forum
FDA Draft Guidance: Clinical Pharmacology Data Use
July 3, 2019 Biosimilars Forum
FDA Guidance: Quality Considerations for Demonstrating Biosimilarity
July 3, 2019 Biosimilars Forum
FDA Guidance: Scientific Considerations in Demonstrating Biosimilarity
July 3, 2019 Biosimilars Forum
Biosimilars: More Treatment Choices and Innovation
  • 01
  • 02
  • 03
  • 04

  • Biosimilars 101
  • Policies
  • Stay Connected
Biosimilars Forum
© 2026 Biosimilars Forum. All rights reserved.
  • Terms of Use
  • |
  • Privacy Policy
  • |
  • Contact Us